Effect of Topical Administration of Monosodium Olpadronate on Experimental Periodontitis in Rats

Journal of Periodontology - Tập 77 Số 1 - Trang 1-6 - 2006
Juan A Goya1, Hugo A. Paez1, Patricia Mandalunis1
1Department of Histology and Embryology, Faculty of Dentistry, University of Buenos Aires, Buenos Aires, Argentina

Tóm tắt

Background: Periodontitis is characterized by gingival inflammation, periodontal pocket formation, and bacterial plaque that lead to alveolar bone destruction. Research studies have recently begun to evaluate the effect of antiresorptive agents using experimental models of periodontitis. Bisphosphonates are the most frequently tested antiresorptive agents; their main effect is inhibition of bone resorption. The aim of this study was to perform a histomorphometric evaluation of the preventive effect of monosodium olpadronate (OPD), an aminobisphosphonate, on experimental periodontitis (EP).Methods: Twenty male Wistar rats were used in this experiment. The animals were assigned to one of two groups: group I: EP; and group II: EP plus topical administration of OPD (EP + OPD). The contralateral side in both groups served as untreated controls (CI and CII), respectively. Mesio‐distally oriented sections of each lower first molar were obtained for histomorphometric evaluation.Results: The treated group (EP + OPD) exhibited marked inhibition of bone loss; interradicular bone volume was significantly greater than that observed in the EP group. The height of the periodontal ligament in the interradicular alveolar bone, which served as an indirect measure of bone loss, was found to be significantly increased in the EP group as compared to the EP + OPD group. Osteoclasts in the OPD treated group were detached from the bone surface, were round in shape, and exhibited a loss of polarity and lack of ruffled borders.Conclusions: The dose used herein was found to inhibit bone loss and to cause marked morphologic changes in osteoclasts. The drug effectively prevented bone loss caused by periodontitis.

Từ khóa


Tài liệu tham khảo

10.1007/s00586-003-0622-z

10.1002/jbmr.5650101008

Fleisch H Bisphosphonates‐Preclinical, 1995, Bisphosphonates in Bone Disease: From the Laboratory to the Patient, 31

10.1002/jbmr.5650050107

10.1210/endo.137.6.8641182

10.1126/science.165.3899.1262

10.1016/j.orthres.2003.12.015

10.1080/1025584042000205327

10.1016/S0889-5406(94)70048-6

10.1177/00220345940730081301

10.1902/jop.2002.73.3.251

10.1902/jop.2001.72.8.1069

10.1111/j.1600-0765.1995.tb02134.x

10.1902/jop.1992.63.10.825

10.1111/j.1600-0765.1994.tb01088.x

10.1902/jop.2002.73.5.479

Ubios AM, 1993, Early steps in bone resorption in experimental periodontitis: A histomorphometric study, Acta Odontol Latinoam, 7, 45

Malluche HH, 1990, Metabolic Bone Disease, 283

10.1902/jop.2003.74.12.1803

Mandalunis PM, 1998, Dynamics of bone loss in experimental periodontitis, Acta Odontol Latinoam, 11, 27

10.1902/jop.1980.51.1.6

10.1902/jop.2004.75.9.1196

10.1016/0169-6009(89)90021-4

Boonekamp PM, 1986, Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix, Bone Miner, 1, 27

10.1007/BF00298728

10.1007/BF00675622

10.1902/jop.2003.74.5.603

10.1902/jop.2000.71.7.1158

10.1902/jop.2000.71.10.1607

10.1902/jop.2000.71.8.1236